These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30107961)

  • 1. Cortactin as a potential predictor of second esophageal neoplasia in hypopharyngeal carcinoma.
    Lien CF; Hwang TZ; Lin TM; Liu KW; Lin BS; Wang CC; Yang CC; Yeh SA
    Auris Nasus Larynx; 2019 Apr; 46(2):260-266. PubMed ID: 30107961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic down-regulation of SOX2 is an independent poor prognostic factor for hypopharyngeal cancers.
    Avincsal MO; Jimbo N; Fujikura K; Shinomiya H; Otsuki N; Morimoto K; Furukawa T; Morita N; Maehara R; Itoh T; Nibu KI; Zen Y
    Histopathology; 2018 Apr; 72(5):826-837. PubMed ID: 29143365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors, and outcomes.
    Wang YK; Chuang YS; Wu TS; Lee KW; Wu CW; Wang HC; Kuo CT; Lee CH; Kuo WR; Chen CH; Wu DC; Wu IC
    Int J Cancer; 2017 Nov; 141(10):1987-1996. PubMed ID: 28758200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide gene expression profile analyses identify CTTN as a potential prognostic marker in esophageal cancer.
    Lu P; Qiao J; He W; Wang J; Jia Y; Sun Y; Tang S; Fu L; Qin Y
    PLoS One; 2014; 9(2):e88918. PubMed ID: 24551190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortactin is a prognostic marker for oral squamous cell carcinoma and its overexpression is involved in oral carcinogenesis.
    Liu YC; Ho HC; Lee MR; Yeh CM; Tseng HC; Lin YC; Chung JG
    Environ Toxicol; 2017 Mar; 32(3):799-812. PubMed ID: 27148699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of Fibroblast growth factor receptor 1 (FGFR1) gene amplification and protein overexpression in hypopharyngeal and laryngeal squamous cell carcinoma.
    Kim EK; Cho YA; Koh YW; Shin HA; Cho BC; Yoon SO
    BMC Cancer; 2020 Apr; 20(1):348. PubMed ID: 32326908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
    Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY
    Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Synchronous ESCN in Head and Neck Cancer: A Single-Institution Perspective.
    Thakur K; Singh CA; Thakar A; Kakkar A; Sikka K; Kumar R; Sharma SC
    Laryngoscope; 2021 Mar; 131(3):E807-E814. PubMed ID: 32619324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of age at diagnosis of head and neck cancer on incidence of metachronous cancer.
    Iwatsubo T; Ishihara R; Morishima T; Maekawa A; Nakagawa K; Arao M; Ohmori M; Iwagami H; Matsuno K; Inoue S; Nakahira H; Matsuura N; Shichijo S; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Miyashiro I; Higuchi K; Fujii T
    BMC Cancer; 2019 Jan; 19(1):3. PubMed ID: 30606157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and clinicopathological significance of CTTN/cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Ramos-García P; González-Moles MÁ; Ayén Á; González-Ruiz L; Ruiz-Ávila I; Gil-Montoya JA
    Head Neck; 2019 Jun; 41(6):1963-1978. PubMed ID: 30597652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the early detection of esophageal neoplasms in hypopharyngeal cancer patients treated with concurrent chemoradiotherapy.
    Watanabe S; Ogino I; Inayama Y; Sugiura M; Sakuma Y; Kokawa A; Kunisaki C; Inoue T
    Asia Pac J Clin Oncol; 2017 Apr; 13(2):e3-e10. PubMed ID: 25359448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck cancer arising after endoscopic mucosal resection for squamous cell carcinoma of the esophagus.
    Shimizu Y; Tsukagoshi H; Fujita M; Hosokawa M; Watanabe A; Kawabori S; Kato M; Sugiyama T; Asaka M
    Endoscopy; 2003 Apr; 35(4):322-6. PubMed ID: 12664389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of REG III and prognosis in head and neck cancer.
    Masui T; Ota I; Itaya-Hironaka A; Takeda M; Kasai T; Yamauchi A; Sakuramoto-Tsuchida S; Mikami S; Yane K; Takasawa S; Hosoi H
    Oncol Rep; 2013 Aug; 30(2):573-8. PubMed ID: 23743605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second esophageal neoplasms after head and neck index tumor: Incidence, risk factors and prognosis.
    Pujol A; Llansana A; Pérez-Ugarte L; Sauter B; Quer M; León X
    Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(6):339-345. PubMed ID: 37149128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Value of Endoscopic Esophageal Screening in Head and Neck Squamous Cell Carcinoma Patients.
    Chen WC; Wu CN; Wang YM; Chiu TJ; Wu SC; Yang YH; Luo SD
    Otolaryngol Head Neck Surg; 2024 Jan; 170(1):141-150. PubMed ID: 37727942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma: a prospective study.
    Gong EJ; Kim DH; Ahn JY; Choi KS; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Kim JH; Roh JL; Choi SH; Nam SY; Kim SY
    Dis Esophagus; 2016 Oct; 29(7):752-759. PubMed ID: 26471351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene sequencing and expression of Raf-1 in lymphatic metastasis of hypopharyngeal carcinoma.
    Li Y; Lu T; Hu G
    Cancer Biomark; 2020; 28(2):181-191. PubMed ID: 32224526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortactin overexpression in the esophageal squamous cell carcinoma and its involvement in the carcinogenesis.
    Hsu NY; Yeh KT; Chiang IP; Pai LY; Chen CY; Ho HC
    Dis Esophagus; 2008; 21(5):402-8. PubMed ID: 19125793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of GRP78/BiP expression in patients with Stage III/IV hypopharyngeal squamous cell carcinoma.
    Kaira K; Toyoda M; Shimizu A; Imai H; Sakakura K; Nikkuni O; Suzuki M; Iijima M; Asao T; Chikamatsu K
    Neoplasma; 2016; 63(3):477-83. PubMed ID: 26952514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.